LAB vs NTAP · rev $174.4M vs P/E 28, rev $6.57B
Standard Biotools Inc (LAB) versus NetApp Inc (NTAP) — a side-by-side from cached financials, not a winner call.
Standard Biotools Inc (LAB) is a medical devices company listed on NASDAQ.
NetApp Inc (NTAP) is a software - infrastructure company listed on US.
Latest reported LAB revenue for 2024-12-31 was $174.4M. Net income was -$138.9M. Revenue was up 64.0% from 2023-12-31 to 2024-12-31. LAB currently screens at market cap $317.1M.
Latest reported NTAP revenue for 2025-04-25 was $6.57B. Net income was $1.19B. Revenue was up 4.9% from 2024-04-26 to 2025-04-25. NTAP currently screens at market cap $35.43B and trailing P/E 28.2.
LAB currently screens at market cap $317.1M. NTAP currently screens at market cap $35.43B and trailing P/E 28.2.
Not investment advice. Open the LAB and NTAP stock pages for the full models.
Not investment advice.